Ligand Pharmaceuticals IncorporatedLGNDNASDAQ
LOADING
|||
EV to Sales History
Trending higher, below historical average, structural decline.
Left:
||||
Enterprise value to sales ratio
Latest
11.34
↓ 27% below average
Average (9y)
15.53
Historical baseline
Range
High:29.91
Low:5.96
CAGR
-10.2%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 11.34 | +22.1% |
| 2023 | 9.28 | +55.7% |
| 2022 | 5.96 | -49.9% |
| 2021 | 11.90 | -3.6% |
| 2020 | 12.34 | -42.0% |
| 2019 | 21.28 | +68.2% |
| 2018 | 12.65 | -38.5% |
| 2017 | 20.57 | +2.4% |
| 2016 | 20.08 | -32.9% |
| 2015 | 29.91 | - |